4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-002849
VP Clinical Reg Affairs bought 250 shares at $19.20 ($4,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Jaye VP Clinical Reg Affairs | 2023-01-27 | Purchase | +250 | $19.20 | $4,800 | 256,995 | D |
| Open-market purchases · 250 sh · avg $19.20 · $4,800 | |||||||
Loading xslF345X03/ownership.xml…